Literature DB >> 20377425

Conserved determinants of enhanced CCR5 binding in the human immunodeficiency virus subtype D envelope third variable loop.

Samaporn Teeravechyan1, M Essex, Tun-Hou Lee.   

Abstract

Human immunodeficiency virus 1 subtype D (HIV-1D) contributes to a significant portion of the HIV-1 disease burden in eastern and central Africa, and is associated with more rapid disease progression. Its viral envelope sequences, particularly in the third variable region (V3), are highly divergent from other major subtypes yet have rarely been studied to date. We evaluated the V3 and select bridging sheet residues of the HIV-1D 94UG114 envelope by alanine-scanning mutagenesis to determine the residues involved in CCR5 usage conservation in the face of sequence variability. We found most single alanine mutations capable of abolishing CCR5 binding, suggesting binding contacts that are highly sensitive to mutation. Despite drastic binding defects across the board, most mutants mediated fusion at or near wild-type levels, demonstrating an ability to accommodate changes in CCR5 affinity while maintaining the ability to complete entry. Three of the alanine mutations did not abolish CCR5 binding but rather resulted in enhanced CCR5 binding. The positions of these residues were found to be conserved between strains of two subtypes, revealing similar V3 elements that suggest a conservation of constraints in V3 loop conformation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20377425      PMCID: PMC2864059          DOI: 10.1089/aid.2009.0086

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  32 in total

Review 1.  An overview of the determinants of CCR5 and CXCR4 co-receptor function.

Authors:  Tatjana Dragic
Journal:  J Gen Virol       Date:  2001-08       Impact factor: 3.891

2.  Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.

Authors:  E G Cormier; D N Tran; L Yukhayeva; W C Olson; T Dragic
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.

Authors:  Pontiano Kaleebu; Neil French; Cedric Mahe; David Yirrell; Christine Watera; Fred Lyagoba; Jessica Nakiyingi; Alleluiah Rutebemberwa; Dilys Morgan; Jonathan Weber; Charles Gilks; Jimmy Whitworth
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

5.  Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor.

Authors:  T Mirzabekov; N Bannert; M Farzan; W Hofmann; P Kolchinsky; L Wu; R Wyatt; J Sodroski
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

6.  CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates.

Authors:  Daniah A D Thompson; Emmanuel G Cormier; Tatjana Dragic
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000.

Authors:  Saladin Osmanov; Claire Pattou; Neff Walker; Bernhard Schwardländer; Jose Esparza
Journal:  J Acquir Immune Defic Syndr       Date:  2002-02-01       Impact factor: 3.731

8.  Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization.

Authors:  Pirada Suphaphiphat; Arunee Thitithanyanont; Saowakon Paca-Uccaralertkun; Max Essex; Tun-Hou Lee
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

9.  The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.

Authors:  Emmanuel G Cormier; Tatjana Dragic
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Relative concordance of human immunodeficiency virus oligomeric and monomeric envelope in CCR5 coreceptor usage.

Authors:  Samaporn Teeravechyan; Pirada Suphaphiphat; Max Essex; Tun-Hou Lee
Journal:  Virology       Date:  2007-10-22       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.